Research is actively being conducted to explore these alternatives and to better understand the molecular mechanisms by which pathogenic E. coli strains cause disease. Identifying virulence factors that enable these bacteria to evade the host's immune response is pivotal. In addition, studies are focused on the use of bacteriophages—viruses that specifically infect bacteria—as a potential therapeutic option to target pathogenic E. coli strains.
